Half-year report · Q2
286A.TEDINET S100WIUD
Period2025-01-01 → 2025-06-30
Filed2025-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥19.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.4bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥981m | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥824m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.0bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥887m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥61.2bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥60.1bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥55.6bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥41.5bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥41.2bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.7bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥19.0bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥14.2bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.2bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.2bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.1bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥419m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥406m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥326m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥856m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.5bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥23.2 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.4 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.44 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥22.75 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥63.12 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 30.3% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.9% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.8% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 49
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥41m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥670m |
| jpcrp040300-q2r_E12328-000Comprehensive Medical Management Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E12328-000Comprehensive Medical Management Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E12328-000Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥395,000 |
| jpcrp040300-q2r_E12328-000Comprehensive Medical Management Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E12328-000Elderly Care Related Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| jpcrp040300-q2r_E12328-000Elderly Care Related Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| jpcrp040300-q2r_E12328-000Elderly Care Related Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥245,000 |
| jpcrp040300-q2r_E12328-000Elderly Care Related Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥187m |
| jpcrp040300-q2r_E12328-000Specially Controlled Medical Device Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E12328-000Specially Controlled Medical Device Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E12328-000Specially Controlled Medical Device Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥276m |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥21m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥21m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥87m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥560m |
| jpcrp040300-q2r_E12328-000Comprehensive Medical Management Support Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.0bn |
| jpcrp040300-q2r_E12328-000Comprehensive Medical Management Support Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.0bn |
| jpcrp040300-q2r_E12328-000Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥9m |
| jpcrp040300-q2r_E12328-000Comprehensive Medical Management Support Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E12328-000Elderly Care Related Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E12328-000Elderly Care Related Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E12328-000Elderly Care Related Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥304m |
| jpcrp040300-q2r_E12328-000Specially Controlled Medical Device Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E12328-000Specially Controlled Medical Device Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E12328-000Specially Controlled Medical Device Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥182m |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥9.4bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥9.4bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥9m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 540
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)Mooreみらい監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)浅 井 清 澄 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)丸 山 清 志 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 9415568000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 10520969000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 19833896000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1639404000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 981021000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 2801668000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 1104707000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 823612000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 2025848000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 1390394000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 770526000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 2217275000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 14207407000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 19740782000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 18951212000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 55600503000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 61219646000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 60148369000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 35.44 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 23.20 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 64.40 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 22.75 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 63.12 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.238 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.303 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.299 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 418919000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -1648231000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1300626000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -325808000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -2408713000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -406469000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 1237061000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 856148000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 3547797000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 8056227000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 8169112000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 11139798000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 37982900 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 37982900 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 37982900 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 37982900 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 16000000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.4493 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |